TUCSON (July 11, 2015) - Evan Unger, President and CEO of NuvOx, announced today that Mike Sember, will join the Board of Directors of NuvOx Pharma. Mike has more than 40 years of comprehensive experience working with public and private pharmaceutical, biotech and medical device companies in the U.S. and Europe. Read More
PHOENIX (July 6, 2015) -
There is a new weapon in the arsenal of radiation-resistant tumor treatments, and a Tucson-based biotechnology company is determined to wipe them out.
NuvOx Pharma has developed a breakthrough nanotechnology that can infuse tumors with oxygen so they become more susceptible to radiation therapy. The technology uses an injected compound that delivers 200 times more oxygen to the body compared to hemoglobin. Read More
TUCSON (June 28, 2015) - NuvOx Pharma has completed a licensing agreement with the University of Pittsburgh for a patent application entitled, “Treatment of Acute Complications of Sickle Cell Disease.” Inventors on the patent are Evan Unger, MD, David Wilson, PhD, both from NuvOx, and Solomon Ofori-Acquah, PhD, from the University of Pittsburgh. Read More
PHOENIX (April 28, 2015) -
The Arizona Commerce Authority (ACA) today met with Dr. Evan Unger, Nuvox Pharma President and CEO to present him with the 2014 Arizona Innovation Challenge Award. Read More
Tucson, AZ (PRWEB) February 01, 2015
Nuvox Pharma is pleased to announce that they have been chosen as one of six winners in the Fall 2014 Arizona Innovation Challenge, sponsored by the Arizona Commerce Authority. Read More
PHOENIX (January 20, 2015) – The Arizona Commerce Authority (ACA) today announced 10 finalists in the Fall 2014 Arizona Innovation Challenge (AIC), its bi-annual business plan competition that awards talented entrepreneurs who are solving today’s most challenging problems with technology-based solutions. Read More
To read more news about NuvOx Pharma, please visit our news page.
To view more NuvOx Pharma publications, please visit our publication page.
This is a comprehensive presentation of the company's Oxygen Nanotechnology Platform for treating life threatening conditions.
Dr. Unger has pioneered original research, championed the clinical translation of his research products, and founded companies in the technology-based private sector to market these products. Dr. Unger's products are routinely used in clinical diagnostic tests that impact the lives of Arizonans and improve healthcare world-wide.
NuvOx Pharma's CBO, David Wilson presents life saving innovation at AZBio Expo 2013
11th in a series of interviews from the ICUS Bubble Conference
Women with breast cancer who are undergoing breast-conserving surgery were assigned to receive whole [...]
Randomized trials demonstrate clear benefits of mammography screening in women through age 74 years. [...]
Linitis plastica is an uncommon ( [...]
A 52-year-old man who was treated with the oral multitargeted receptor tyrosine kinase inhibitor sun [...]
Imaging studies could not capture the source of a 70-year-old woman's pulmonary hypertension an [...]